The National Institutes of Health (NIH) has announced a funding opportunity titled "Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials." This initiative aims to establish a national network that will develop, validate, standardize, and disseminate measurement methods for primary prevention trials focused on AD and ADRD, particularly addressing brain health equity among underserved populations. The network will serve as a centralized hub for innovative measurement approaches that encompass cognitive, behavioral, biological, and social factors impacting brain health. A total budget of $8 million is allocated for one award over a maximum period of five years, with applications due by June 15, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.